Stereotactic Ablative RT
1 clinical trials · Condition
◉ Watch Stereotactic Ablative RT
| Record | Firm | Date |
|---|---|---|
| MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02) (NCT05183074) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-02-01 |
Track Stereotactic Ablative RT automatically
Every clearance here is in the API, with alerts when new ones post.